Dr. Gang Xu 徐岗
Chief Physician
Department of Thoracic Surgery, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and multidisciplinary treatment of esophageal cancer, lung cancer, and breast cancer. Focus on totally thoracoscopic minimally invasive surgery for esophageal cancer, lung cancer, and mediastinal tumors.
Dr. Xu holds a medical doctorate and serves as a flexible aid-to-Xinjiang expert in Guangdong. Research focuses on basic and clinical studies of esophageal and lung cancer, with specific expertise in diagnosing and treating small pulmonary nodules. Clinical work aims to optimize minimally invasive thoracic surgeries to reduce perioperative complications in elderly patients or those with poor cardiopulmonary function.
Professional roles
- Member, Esophageal Cancer Professional Committee, Guangdong Anti-Cancer Association
- Member, Thoracic Surgery Management Branch, Guangdong Medical Industry Association
- Expert, Health Science Popularization, Guangdong Province
- Expert, Medical Malpractice Appraisal Committee, Guangzhou Medical Association
Name order: in Chinese the family name comes first (Xu Gang). Papers usually list the name as Gang Xu or Xu G.
Selected publications
9 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- Elife, 2026 (senior author): Molecular architecture of the tumor microenvironment caused by BRCA1 and BRCA2 somatic mutations in human lung adenocarcinoma. PubMed 42189716
- J Thorac Dis, 2025 (senior author): Impact of platinum-based adjuvant chemotherapy on the effectiveness of IB-IIIA non-small cell lung adenocarcinoma with varying EGFR mutation statuses: a propensity score matching analysis. PubMed 40688312
- Minerva Med, 2021 (senior author): MicroRNA-920 enhances chemosensitivity in esophageal squamous cell carcinoma by targeting YAP. PubMed 34633158
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion